Verastem (VSTM) Times Interest Earned (2017 - 2026)
Verastem (VSTM) recorded quarterly Times Interest Earned of -$117.53 in Q1 2026, down 157.61% quarter-over-quarter from $204.01 in Q4 2025, and up 48.92% on a YoY basis from -$78.92 in Q1 2025.
Verastem (VSTM) Times Interest Earned (2017 - 2026) Analysis & Trends
Verastem's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$117.53 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 48.92% year-over-year to -$117.53; the TTM figure through Mar 2026 stood at -$36.77 (down 1.66% YoY), while the FY2025 annual figure was -$38.65, down 53.4% from the prior year.
- Times Interest Earned was -$117.53 for Q1 2026 at Verastem, down from $204.01 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $204.01 in Q4 2025 to a low of -$437.64 in Q2 2025.
- Historically, Times Interest Earned has averaged -$75.54 across 5 years, with a median of -$27.57 in 2024.
- Biggest YoY gain for Times Interest Earned was 840.1% in 2025; the steepest drop was 2624.92% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$23.27 in 2022, then retreated by 19.49% to -$27.8 in 2023, then advanced by 0.85% to -$27.57 in 2024, then soared by 840.1% to $204.01 in 2025, then plunged by 157.61% to -$117.53 in 2026.
- The last three Times Interest Earned figures came in at -$117.53 (Q1 2026), $204.01 (Q4 2025), and -$127.63 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | -117.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -117.53 |
| Dec 31, 2025 | 204.01 |
| Sep 30, 2025 | -127.63 |
| Jun 30, 2025 | -437.64 |
| Mar 31, 2025 | -230.07 |
| Dec 31, 2024 | -27.57 |
| Sep 30, 2024 | -32.26 |
| Jun 30, 2024 | -16.06 |
| Mar 31, 2024 | -24.83 |
| Dec 31, 2023 | -27.80 |
| Sep 30, 2023 | -18.87 |
| Jun 30, 2023 | -18.10 |
| Mar 31, 2023 | -25.15 |
| Dec 31, 2022 | -23.27 |
| Sep 30, 2022 | -24.70 |
| Jun 30, 2022 | -33.44 |
| Mar 31, 2022 | -303.21 |
| Dec 31, 2021 | -1,651.10 |
| Sep 30, 2021 | -1.86 |
| Jun 30, 2021 | -15.83 |